Chad vs Kazakhstan: The number of people with susceptibility test result for rifampicin
Chad
7,424
in 2021
Kazakhstan
5,121
in 2021
Chad rank
26th
Kazakhstan rank
28th
The number of people with susceptibility test result for rifampicin over time
- Chad
- Kazakhstan
How they compare
Chad currently reports 7,424 against 5,121 in Kazakhstan, a difference of 2,303.
That makes Chad's figure about 1.4 times Kazakhstan's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Kazakhstan ahead.
Chad ranks 26th and Kazakhstan ranks 28th of 155 countries.
Across the 2 decades both report, Chad averaged higher in 1 and Kazakhstan in 1.
Head to head by decade
| Decade | Chad | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 726.67 | 5,272 | 4,545 | Kazakhstan |
| 2020s | 5,036 | 4,990 | 46.5 | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Chad or Kazakhstan?
- Chad, at 7,424 against 5,121 in Kazakhstan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Chad and Kazakhstan?
- 2,303, with Chad ahead.
- How many years of comparable data are there for Chad and Kazakhstan?
- 5 years are reported by both, from 2017 to 2021.
- How do Chad and Kazakhstan rank globally for the number of people with susceptibility test result for rifampicin?
- Chad ranks 26th and Kazakhstan ranks 28th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.